D18G (p.Asp18Gly) variant of NF1 (Neurofibromin)

D18G (p.Asp18Gly) in NF1 (Neurofibromin) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.31 / 1. The record also includes population frequency data, published literature, and structural context.

D18G (p.Asp18Gly) variant details